Email Updates

You are here

AVAC's Blog: P-Values

  • The WHO Working Group has articulated important criteria for assessing a challenge study, but we believe that they left out the most important one: Until there is an approved treatment, a challenge trial with a potentially fatal and as-yet untreatable pathogen is unacceptable.

    May 7, 2020
    AVAC
    Treatment Action Group
  • To make headway against both HIV and COVID-19, we must demand commitment to science and evidence, collaboration and innovation. And we must work together with undaunted commitment.

    May 5, 2020
    General
    AVAC
  • For women all over the world, getting the products and services they need and want for HIV prevention and for sexual & reproductive health (SRH) are mired in challenges – and COVID-19 is intensifying the struggle. Siloed care, stock outs, and too little input from women themselves on the design of programs and products are among the long-standing barriers to women’s healthcare, and COVID-19 exacerbates these difficulties. AVAC is expanding our partnerships and programs to meet these challenges.

    April 30, 2020
    AVAC
  • New COVID-19 mathematical models are emerging to predict trends in new infections and deaths in cities, countries and globally. These models can forecast medical supply shortages, and influence policy makers and investment of resources. Strengthening our understanding of current models, how they are developed, and their limitations, allows us to better apply modeling to public health policies and programs.

    April 28, 2020
    AVAC
  • In the midst of the global response to COVID-19, everyone and everything is affected, and HIV prevention research is no exception.

    April 21, 2020
    AVAC
  • More than 260 organizations and individuals have joined an Advocates Call for Ethical Research for COVID-19 Solutions. Read the letter reiterating the essential role of ethical research, and the need to move forward based on facts and evidence, and help us carry this message forward!

    April 20, 2020
    AVAC
  • AVAC, Health GAP, Knowledge Ecology International (KEI) and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.
    April 16, 2020
    AVAC
    Health GAP
    Knowledge Ecology International
    Treatment Action Group
  • On the heels of our spotlight last week looking at the intersection of COVID-19 and HIV, this edition of the Advocates Network features new resources for HIV prevention research and advocacy, work that’s as important today as ever before. Both HIV and COVID-19 are urgent matters of public health, demanding a sustained commitment. Use these tools to stay informed and connected, and scroll down for COVID-19 materials.

    April 15, 2020
    AVAC
  • Integrating HIV and SRH has been successfully put into practice for family planning in HIV care and treatment clinics and prevention of mother-to-child transmission services in maternal and child health clinics. But integrating HIV prevention—most recently the addition of oral PrEP—and SRH services has been slow.

    April 14, 2020
    AVAC
  • The 3Ps for Prevention (Partners, Perceptions and Pills) study (3P) on PrEP use among adolescent girls and young women incorporated a photography project as a way for the young women to document their experience with PrEP. The images they created gave researchers a unique view into participants’ perspectives on PrEP, revealing new dimensions to their experience and the factors that encourage or discourage PrEP use.

    April 10, 2020
    AVAC
    RTI International

Pages